Published July 2013 | Version v1
Journal article

Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy

  • 1. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi (India)

Description

Lytic bone metastases are rare in prostate cancer. We here present 18 fluorine fluorodeoxyglucose (18F-FDG) positron emission tomography computed tomography (PET-CT) images of a 67-year-old male patient with lytic metastases from prostate cancer. Repeat 18F-FDG PET-CT done 6 months later showed response to medical castration therapy. While the role of 18F-FDG PET-CT for sclerotic bone metastases in prostate cancer remains controversial, it appears to be useful for detection and response assessment of lytic prostate cancer metastases. (author)

Additional details

Publishing Information

Journal Title
Indian Journal of Nuclear Medicine
Journal Volume
28
Journal Issue
3
Journal Page Range
p. 178-179
CODEN
IJNMEK

Optional Information

Notes
9 refs., 1 fig.